Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common ED drug and cycling help kids with duchenne?

NCT ID NCT06290713

First seen May 22, 2026

Summary

This study is testing whether a drug called tadalafil (often used for erectile dysfunction) combined with a home cycling program can help boys with Duchenne muscular dystrophy. The drug aims to improve blood flow to muscles, which is often poor in DMD, while exercise builds strength and endurance. About 50 ambulatory boys aged 6 and older will take either tadalafil or a placebo daily for 6 months and do weekly cycling sessions. The goal is to see if this combo can improve muscle function and fatigue resistance.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXERCISE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Florida Clinical and Translational Research Building

    RECRUITING

    Gainesville, Florida, 32603, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Tadalafil (a drug that widens blood vessels) and a home-based cycling exercise program

What this could lead to

If successful, this could point toward a new way to improve muscle function and slow disease progression in Duchenne muscular dystrophy by combining a common blood-flow drug with exercise.

What could go wrong

This is a small, early-phase trial with only 50 participants, so results may not apply to everyone. The drug and exercise may not improve muscle function as hoped, and there are risks like side effects from tadalafil or injury from exercise.

Conditions

The condition(s) this trial relates to.

Aneurysm Duchenne muscular dystrophy Motor Activity muscular dystrophy tabes dorsalis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.